4.7 Article

PTH 1-34 promoted bone formation by regulating iron metabolism in unloading-induced bone loss

Related references

Note: Only part of the references are listed.
Article Oncology

Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1α, Wnt/β-Catenin, and p38MAPK/ERK Pathways

Hongliang You et al.

Summary: This study found that deferoxamine (DFO) effectively reduced the concentration of intracellular iron in ALL cells, inhibiting cell proliferation and inducing apoptosis. The combination of DFO and dextriferron (Dex) decreased the sensitivity of ALL cells to DFO. Additionally, DFO inhibited tumor growth in mice and affected multiple signaling pathways involved in cell cycle regulation and cell survival.

JOURNAL OF ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis

Tiago L. Duarte et al.

Summary: This review discusses the roles of oxygen-sensing pathways in iron homeostasis regulation, highlighting the significance of NRF2 in macrophages and the interaction between low iron/hypoxia and HIF2a in renal and intestinal tissues. The close crosstalk between oxygen-sensing pathways and iron regulatory mechanisms ensures prompt detection and restoration of systemic iron levels. Future therapeutic approaches may target redox-sensitive transcription factors to regulate iron levels systemically.

ANTIOXIDANTS & REDOX SIGNALING (2021)

Article Endocrinology & Metabolism

Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice

Mikkel Bo Brent et al.

Summary: The combination therapy of ActRIIA-mFc and PTH was more effective in preventing disuse-induced bone loss and deterioration of trabecular micro-architecture than either treatment alone.
Review Pharmacology & Pharmacy

HO-1: A new potential therapeutic target to combat osteoporosis

Jingmin Che et al.

Summary: HO-1 plays a crucial role in osteoporosis by regulating mechanisms such as inflammation and oxidative stress to slow the progression of the disease. Therapies targeting HO-1 may offer new potential treatment options for osteoporosis.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

The Effect of Abnormal Iron Metabolism on Osteoporosis

Jingmin Che et al.

BIOLOGICAL TRACE ELEMENT RESEARCH (2020)

Article Endocrinology & Metabolism

Disorder of Iron Metabolism Inhibits the Recovery of Unloading-Induced Bone Loss in Hypomagnetic Field

Yanru Xue et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2020)

Review Engineering, Aerospace

Iron overload as a high risk factor for microgravity-induced bone loss

Xin Chen et al.

ACTA ASTRONAUTICA (2019)

Article Cell Biology

Icariin protects against iron overload-induced bone loss via suppressing oxidative stress

Xingzhi Jing et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Endocrinology & Metabolism

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

J. A. Kanis et al.

OSTEOPOROSIS INTERNATIONAL (2019)

Article Endocrinology & Metabolism

Nrf2 controls iron homoeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin

Pei Jin Lim et al.

NATURE METABOLISM (2019)

Article Endocrinology & Metabolism

PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats

Mikkel Bo Brent et al.

Review Rheumatology

Skeletal changes during and after spaceflight

Laurence Vico et al.

NATURE REVIEWS RHEUMATOLOGY (2018)

Article Medicine, Research & Experimental

Regulation of Bone Remodeling by Parathyroid Hormone

Marc N. Wein et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Review Biochemistry & Molecular Biology

The Roles of NRF2 in Modulating Cellular Iron Homeostasis

Michael John Kerins et al.

ANTIOXIDANTS & REDOX SIGNALING (2018)

Review Urology & Nephrology

Parathyroid hormone metabolism and signaling in health and chronic kidney disease

Pieter Evenepoel et al.

KIDNEY INTERNATIONAL (2016)

Review Medicine, General & Internal

Hepcidin: A Promising Therapeutic Target for Iron Disorders A Systematic Review

Jing Liu et al.

MEDICINE (2016)

Article Biochemistry & Molecular Biology

Molecular basis of the Keap1-Nrf2 system

Takafumi Suzuki et al.

FREE RADICAL BIOLOGY AND MEDICINE (2015)

Article Endocrinology & Metabolism

Role of the Parathyroid Hormone Type 1 Receptor (PTH1R) as a Mechanosensor in Osteocyte Survival

Marta Maycas et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2015)

Review Endocrinology & Metabolism

PTH receptor-1 signalling-mechanistic insights and therapeutic prospects

Ross W. Cheloha et al.

NATURE REVIEWS ENDOCRINOLOGY (2015)

Article Physiology

Bone metabolism and nutritional status during 30-day head-down-tilt bed rest

Jennifer L. L. Morgan et al.

JOURNAL OF APPLIED PHYSIOLOGY (2012)

Article Endocrinology & Metabolism

Safety of Osteoanabolic Therapy: A Decade of Experience

Cristiana Capriani et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2012)

Article Endocrinology & Metabolism

Benefits for bone from resistance exercise and nutrition in long-duration spaceflight: Evidence from biochemistry and densitometry

Scott M. Smith et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2012)

Review Endocrinology & Metabolism

Parathyroid hormone analogues in the treatment of osteoporosis

Marius E. Kraenzlin et al.

NATURE REVIEWS ENDOCRINOLOGY (2011)

Article Hematology

Pathogenesis and management of iron toxicity in thalassemia

Chaim Hershko

COOLEY'S ANEMIA: NINTH SYMPOSIUM (2010)

Article Endocrinology & Metabolism

Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage

Daniel D. Bikle et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2010)

Review Endocrinology & Metabolism

Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography

Mary L. Bouxsein et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2010)

Article Endocrinology & Metabolism

Disuse Osteopenia

Susan A. Bloomfield

Current Osteoporosis Reports (2010)

Article Biochemistry & Molecular Biology

Hepcidin, the iron watcher

Lydie Viatte et al.

BIOCHIMIE (2009)

Article Genetics & Heredity

BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism

Billy Andriopoulos et al.

NATURE GENETICS (2009)

Article Biochemistry & Molecular Biology

Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids

Maria Almeida et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Medicine, General & Internal

The role of DXA bone density scans in the diagnosis and treatment of osteoporosis

Glen M. Blake et al.

POSTGRADUATE MEDICAL JOURNAL (2007)

Article Endocrinology & Metabolism

Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats

Russell T. Turner et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2007)

Article Biochemistry & Molecular Biology

Redox regulation of the transcriptional repressor Bach1

M Ishikawa et al.

FREE RADICAL BIOLOGY AND MEDICINE (2005)

Article Endocrinology & Metabolism

Genetically linked site-specificity of disuse osteoporosis

S Judex et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2004)

Review Multidisciplinary Sciences

Control of osteoblast function and regulation of bone mass

S Harada et al.

NATURE (2003)

Review Physiology

Hindlimb unloading rodent model: technical aspects

ER Morey-Holton et al.

JOURNAL OF APPLIED PHYSIOLOGY (2002)

Article Medicine, General & Internal

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

RM Neer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Biochemistry & Molecular Biology

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

CH Park et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)